Global Guillain-Barre Syndrome Market Size, Share & Trends Analysis Report By Therapeutics (Intravenous Immunoglobulin, Plasma Exchange, and Others), By Route Of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030
Published Date : 29-Mar-2024 |
Pages: 233 |
Formats: PDF |
COVID-19 Impact on the Guillain-Barre Syndrome Market
Market Overview
The Global Guillain-Barre Syndrome Market size is expected to reach $852.2 billion by 2030, rising at a market growth of 4.6% CAGR during the forecast period.
North America, particularly the United States and Canada, has a robust healthcare infrastructure with high healthcare spending levels. Thus, the North America segment captured 36.2% revenue share in the market 2022. According to the Government of Canada, since 2014, approximately half of all cases of AFP that have been identified in Canada have been diagnosed with Guillain-Barré syndrome, and approximately twenty percent of those cases have been diagnosed with transverse myelitis.
GBS primarily affects adults, with the highest incidence rates observed in individuals aged 50 and older. As the global population ages, there’s a natural increase in the number of people at risk for GBS, which contributes to the rising prevalence of the condition.
Additionally, according to World Bank data, the World Bank Board of Directors approved US$50 million in new financing for Argentina to improve access to public healthcare services and ensure continued service for 6.5 million residents of the province of Buenos Aires without private health insurance. In conclusion, increasing global healthcare expenditures are driving the market’s growth.
However, the acute phase of GBS often requires hospitalization, intensive care, and specialized medical interventions such as plasma exchange and intravenous immunoglobulin (IVIG) therapy. These treatments can incur substantial healthcare costs, including hospital charges, medication expenses, and physician fees, placing financial strain on patients and healthcare systems. Thus, the high cost of treatment is impeding the market’s growth.
By Therapeutics Analysis
Based on therapeutics, the market is bifurcated into intravenous immunoglobulin, plasma exchange, and others. In 2022, the intravenous immunoglobulin segment garnered 50.9% revenue share in the market. Intravenous immunoglobulin exerts its therapeutic effects through multiple mechanisms, including modulating immune responses.
By Route Of Administration Analysis
On the basis of the route of administration, the market is segmented into parenteral and oral. In 2022, the oral segment attained a noteworthy revenue share in the market. Oral medications are increasingly utilized for early intervention in GBS cases with mild symptoms or as maintenance therapy following the acute phase of the disease.
By Distribution Channel Analysis
Based on distribution channel, the market is categorized into retail pharmacies, hospital pharmacies, and others. In 2022, the hospital pharmacies segment registered 48.8% revenue share in the market. GBS management typically involves a multidisciplinary team of healthcare professionals, including neurologists, intensivists, physiotherapists, and pharmacists, working together to provide comprehensive patient care.
Free Valuable Insights: Global Guillain-Barre Syndrome Market size to reach USD 852.2 Million by 2030
By Regional Analysis
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region generated 28.2% revenue share in the market. The diagnostic rate of neurological illnesses, including GBS, has improved in the Asia-Pacific region due to increased public and healthcare professional knowledge.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 602 Million |
| Market size forecast in 2030 | USD 852.2 Million |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 4.6% from 2023 to 2030 |
| Number of Pages | 233 |
| Number of Tables | 340 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Solution, Technology, Application, Vertical, Region |
| Country scope |
|
| Companies Included | F. Hoffmann-La Roche Ltd., Pfizer, Inc., PTC, Inc., AstraZeneca PLC, Novartis AG, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co., Inc., Bristol Myers Squibb Company |
List of Key Companies Profiled
- F.Hoffmann-La Roche Ltd.
- Pfizer, Inc.
- PTC, Inc.
- AstraZeneca PLC
- Novartis AG
- Novo Nordisk A/S
- Takeda Pharmaceutical Company Limited
- Bayer AG
- Merck & Co., Inc.
- Bristol Myers Squibb Company
Guillain-Barre Syndrome Market Report Segmentation
By Therapeutics
- Intravenous Immunoglobulin
- Plasma Exchange
- Others
By Route Of Administration
- Parenteral
- Oral
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Guillain-Barre Syndrome Market, by Therapeutics
1.4.2 Global Guillain-Barre Syndrome Market, by Route Of Administration
1.4.3 Global Guillain-Barre Syndrome Market, by Distribution Channel
1.4.4 Global Guillain-Barre Syndrome Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global Guillain-Barre Syndrome Market by Therapeutics
4.1 Global Intravenous Immunoglobulin Market by Region
4.2 Global Plasma Exchange Market by Region
4.3 Global Others Market by Region
Chapter 5. Global Guillain-Barre Syndrome Market by Route Of Administration
5.1 Global Parenteral Market by Region
5.2 Global Oral Market by Region
Chapter 6. Global Guillain-Barre Syndrome Market by Distribution Channel
6.1 Global Hospital Pharmacies Market by Region
6.2 Global Retail Pharmacies Market by Region
6.3 Global Others Market by Region
Chapter 7. Global Guillain-Barre Syndrome Market by Region
7.1 North America Guillain-Barre Syndrome Market
7.1.1 North America Guillain-Barre Syndrome Market by Therapeutics
7.1.1.1 North America Intravenous Immunoglobulin Market by Country
7.1.1.2 North America Plasma Exchange Market by Country
7.1.1.3 North America Others Market by Country
7.1.2 North America Guillain-Barre Syndrome Market by Route Of Administration
7.1.2.1 North America Parenteral Market by Country
7.1.2.2 North America Oral Market by Country
7.1.3 North America Guillain-Barre Syndrome Market by Distribution Channel
7.1.3.1 North America Hospital Pharmacies Market by Country
7.1.3.2 North America Retail Pharmacies Market by Country
7.1.3.3 North America Others Market by Country
7.1.4 North America Guillain-Barre Syndrome Market by Country
7.1.4.1 US Guillain-Barre Syndrome Market
7.1.4.1.1 US Guillain-Barre Syndrome Market by Therapeutics
7.1.4.1.2 US Guillain-Barre Syndrome Market by Route Of Administration
7.1.4.1.3 US Guillain-Barre Syndrome Market by Distribution Channel
7.1.4.2 Canada Guillain-Barre Syndrome Market
7.1.4.2.1 Canada Guillain-Barre Syndrome Market by Therapeutics
7.1.4.2.2 Canada Guillain-Barre Syndrome Market by Route Of Administration
7.1.4.2.3 Canada Guillain-Barre Syndrome Market by Distribution Channel
7.1.4.3 Mexico Guillain-Barre Syndrome Market
7.1.4.3.1 Mexico Guillain-Barre Syndrome Market by Therapeutics
7.1.4.3.2 Mexico Guillain-Barre Syndrome Market by Route Of Administration
7.1.4.3.3 Mexico Guillain-Barre Syndrome Market by Distribution Channel
7.1.4.4 Rest of North America Guillain-Barre Syndrome Market
7.1.4.4.1 Rest of North America Guillain-Barre Syndrome Market by Therapeutics
7.1.4.4.2 Rest of North America Guillain-Barre Syndrome Market by Route Of Administration
7.1.4.4.3 Rest of North America Guillain-Barre Syndrome Market by Distribution Channel
7.2 Europe Guillain-Barre Syndrome Market
7.2.1 Europe Guillain-Barre Syndrome Market by Therapeutics
7.2.1.1 Europe Intravenous Immunoglobulin Market by Country
7.2.1.2 Europe Plasma Exchange Market by Country
7.2.1.3 Europe Others Market by Country
7.2.2 Europe Guillain-Barre Syndrome Market by Route Of Administration
7.2.2.1 Europe Parenteral Market by Country
7.2.2.2 Europe Oral Market by Country
7.2.3 Europe Guillain-Barre Syndrome Market by Distribution Channel
7.2.3.1 Europe Hospital Pharmacies Market by Country
7.2.3.2 Europe Retail Pharmacies Market by Country
7.2.3.3 Europe Others Market by Country
7.2.4 Europe Guillain-Barre Syndrome Market by Country
7.2.4.1 Germany Guillain-Barre Syndrome Market
7.2.4.1.1 Germany Guillain-Barre Syndrome Market by Therapeutics
7.2.4.1.2 Germany Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.1.3 Germany Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.2 UK Guillain-Barre Syndrome Market
7.2.4.2.1 UK Guillain-Barre Syndrome Market by Therapeutics
7.2.4.2.2 UK Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.2.3 UK Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.3 France Guillain-Barre Syndrome Market
7.2.4.3.1 France Guillain-Barre Syndrome Market by Therapeutics
7.2.4.3.2 France Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.3.3 France Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.4 Russia Guillain-Barre Syndrome Market
7.2.4.4.1 Russia Guillain-Barre Syndrome Market by Therapeutics
7.2.4.4.2 Russia Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.4.3 Russia Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.5 Spain Guillain-Barre Syndrome Market
7.2.4.5.1 Spain Guillain-Barre Syndrome Market by Therapeutics
7.2.4.5.2 Spain Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.5.3 Spain Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.6 Italy Guillain-Barre Syndrome Market
7.2.4.6.1 Italy Guillain-Barre Syndrome Market by Therapeutics
7.2.4.6.2 Italy Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.6.3 Italy Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.7 Rest of Europe Guillain-Barre Syndrome Market
7.2.4.7.1 Rest of Europe Guillain-Barre Syndrome Market by Therapeutics
7.2.4.7.2 Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.7.3 Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel
7.3 Asia Pacific Guillain-Barre Syndrome Market
7.3.1 Asia Pacific Guillain-Barre Syndrome Market by Therapeutics
7.3.1.1 Asia Pacific Intravenous Immunoglobulin Market by Country
7.3.1.2 Asia Pacific Plasma Exchange Market by Country
7.3.1.3 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration
7.3.2.1 Asia Pacific Parenteral Market by Country
7.3.2.2 Asia Pacific Oral Market by Country
7.3.3 Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel
7.3.3.1 Asia Pacific Hospital Pharmacies Market by Country
7.3.3.2 Asia Pacific Retail Pharmacies Market by Country
7.3.3.3 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Guillain-Barre Syndrome Market by Country
7.3.4.1 China Guillain-Barre Syndrome Market
7.3.4.1.1 China Guillain-Barre Syndrome Market by Therapeutics
7.3.4.1.2 China Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.1.3 China Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.2 Japan Guillain-Barre Syndrome Market
7.3.4.2.1 Japan Guillain-Barre Syndrome Market by Therapeutics
7.3.4.2.2 Japan Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.2.3 Japan Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.3 India Guillain-Barre Syndrome Market
7.3.4.3.1 India Guillain-Barre Syndrome Market by Therapeutics
7.3.4.3.2 India Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.3.3 India Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.4 South Korea Guillain-Barre Syndrome Market
7.3.4.4.1 South Korea Guillain-Barre Syndrome Market by Therapeutics
7.3.4.4.2 South Korea Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.4.3 South Korea Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.5 Singapore Guillain-Barre Syndrome Market
7.3.4.5.1 Singapore Guillain-Barre Syndrome Market by Therapeutics
7.3.4.5.2 Singapore Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.5.3 Singapore Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.6 Malaysia Guillain-Barre Syndrome Market
7.3.4.6.1 Malaysia Guillain-Barre Syndrome Market by Therapeutics
7.3.4.6.2 Malaysia Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.6.3 Malaysia Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.7 Rest of Asia Pacific Guillain-Barre Syndrome Market
7.3.4.7.1 Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics
7.3.4.7.2 Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.7.3 Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel
7.4 LAMEA Guillain-Barre Syndrome Market
7.4.1 LAMEA Guillain-Barre Syndrome Market by Therapeutics
7.4.1.1 LAMEA Intravenous Immunoglobulin Market by Country
7.4.1.2 LAMEA Plasma Exchange Market by Country
7.4.1.3 LAMEA Others Market by Country
7.4.2 LAMEA Guillain-Barre Syndrome Market by Route Of Administration
7.4.2.1 LAMEA Parenteral Market by Country
7.4.2.2 LAMEA Oral Market by Country
7.4.3 LAMEA Guillain-Barre Syndrome Market by Distribution Channel
7.4.3.1 LAMEA Hospital Pharmacies Market by Country
7.4.3.2 LAMEA Retail Pharmacies Market by Country
7.4.3.3 LAMEA Others Market by Country
7.4.4 LAMEA Guillain-Barre Syndrome Market by Country
7.4.4.1 Brazil Guillain-Barre Syndrome Market
7.4.4.1.1 Brazil Guillain-Barre Syndrome Market by Therapeutics
7.4.4.1.2 Brazil Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.1.3 Brazil Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.2 Argentina Guillain-Barre Syndrome Market
7.4.4.2.1 Argentina Guillain-Barre Syndrome Market by Therapeutics
7.4.4.2.2 Argentina Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.2.3 Argentina Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.3 UAE Guillain-Barre Syndrome Market
7.4.4.3.1 UAE Guillain-Barre Syndrome Market by Therapeutics
7.4.4.3.2 UAE Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.3.3 UAE Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.4 Saudi Arabia Guillain-Barre Syndrome Market
7.4.4.4.1 Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics
7.4.4.4.2 Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.4.3 Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.5 South Africa Guillain-Barre Syndrome Market
7.4.4.5.1 South Africa Guillain-Barre Syndrome Market by Therapeutics
7.4.4.5.2 South Africa Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.5.3 South Africa Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.6 Nigeria Guillain-Barre Syndrome Market
7.4.4.6.1 Nigeria Guillain-Barre Syndrome Market by Therapeutics
7.4.4.6.2 Nigeria Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.6.3 Nigeria Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.7 Rest of LAMEA Guillain-Barre Syndrome Market
7.4.4.7.1 Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics
7.4.4.7.2 Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.7.3 Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel
Chapter 8. Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 PTC, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Novartis AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Novo Nordisk A/S
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Takeda Pharmaceutical Company Limited
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bayer AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Bristol Myers Squibb Company
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Chapter 9. Winning Imperatives of Guillain-Barre Syndrome Market
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Guillain-Barre Syndrome Market, by Therapeutics
1.4.2 Global Guillain-Barre Syndrome Market, by Route Of Administration
1.4.3 Global Guillain-Barre Syndrome Market, by Distribution Channel
1.4.4 Global Guillain-Barre Syndrome Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global Guillain-Barre Syndrome Market by Therapeutics
4.1 Global Intravenous Immunoglobulin Market by Region
4.2 Global Plasma Exchange Market by Region
4.3 Global Others Market by Region
Chapter 5. Global Guillain-Barre Syndrome Market by Route Of Administration
5.1 Global Parenteral Market by Region
5.2 Global Oral Market by Region
Chapter 6. Global Guillain-Barre Syndrome Market by Distribution Channel
6.1 Global Hospital Pharmacies Market by Region
6.2 Global Retail Pharmacies Market by Region
6.3 Global Others Market by Region
Chapter 7. Global Guillain-Barre Syndrome Market by Region
7.1 North America Guillain-Barre Syndrome Market
7.1.1 North America Guillain-Barre Syndrome Market by Therapeutics
7.1.1.1 North America Intravenous Immunoglobulin Market by Country
7.1.1.2 North America Plasma Exchange Market by Country
7.1.1.3 North America Others Market by Country
7.1.2 North America Guillain-Barre Syndrome Market by Route Of Administration
7.1.2.1 North America Parenteral Market by Country
7.1.2.2 North America Oral Market by Country
7.1.3 North America Guillain-Barre Syndrome Market by Distribution Channel
7.1.3.1 North America Hospital Pharmacies Market by Country
7.1.3.2 North America Retail Pharmacies Market by Country
7.1.3.3 North America Others Market by Country
7.1.4 North America Guillain-Barre Syndrome Market by Country
7.1.4.1 US Guillain-Barre Syndrome Market
7.1.4.1.1 US Guillain-Barre Syndrome Market by Therapeutics
7.1.4.1.2 US Guillain-Barre Syndrome Market by Route Of Administration
7.1.4.1.3 US Guillain-Barre Syndrome Market by Distribution Channel
7.1.4.2 Canada Guillain-Barre Syndrome Market
7.1.4.2.1 Canada Guillain-Barre Syndrome Market by Therapeutics
7.1.4.2.2 Canada Guillain-Barre Syndrome Market by Route Of Administration
7.1.4.2.3 Canada Guillain-Barre Syndrome Market by Distribution Channel
7.1.4.3 Mexico Guillain-Barre Syndrome Market
7.1.4.3.1 Mexico Guillain-Barre Syndrome Market by Therapeutics
7.1.4.3.2 Mexico Guillain-Barre Syndrome Market by Route Of Administration
7.1.4.3.3 Mexico Guillain-Barre Syndrome Market by Distribution Channel
7.1.4.4 Rest of North America Guillain-Barre Syndrome Market
7.1.4.4.1 Rest of North America Guillain-Barre Syndrome Market by Therapeutics
7.1.4.4.2 Rest of North America Guillain-Barre Syndrome Market by Route Of Administration
7.1.4.4.3 Rest of North America Guillain-Barre Syndrome Market by Distribution Channel
7.2 Europe Guillain-Barre Syndrome Market
7.2.1 Europe Guillain-Barre Syndrome Market by Therapeutics
7.2.1.1 Europe Intravenous Immunoglobulin Market by Country
7.2.1.2 Europe Plasma Exchange Market by Country
7.2.1.3 Europe Others Market by Country
7.2.2 Europe Guillain-Barre Syndrome Market by Route Of Administration
7.2.2.1 Europe Parenteral Market by Country
7.2.2.2 Europe Oral Market by Country
7.2.3 Europe Guillain-Barre Syndrome Market by Distribution Channel
7.2.3.1 Europe Hospital Pharmacies Market by Country
7.2.3.2 Europe Retail Pharmacies Market by Country
7.2.3.3 Europe Others Market by Country
7.2.4 Europe Guillain-Barre Syndrome Market by Country
7.2.4.1 Germany Guillain-Barre Syndrome Market
7.2.4.1.1 Germany Guillain-Barre Syndrome Market by Therapeutics
7.2.4.1.2 Germany Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.1.3 Germany Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.2 UK Guillain-Barre Syndrome Market
7.2.4.2.1 UK Guillain-Barre Syndrome Market by Therapeutics
7.2.4.2.2 UK Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.2.3 UK Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.3 France Guillain-Barre Syndrome Market
7.2.4.3.1 France Guillain-Barre Syndrome Market by Therapeutics
7.2.4.3.2 France Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.3.3 France Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.4 Russia Guillain-Barre Syndrome Market
7.2.4.4.1 Russia Guillain-Barre Syndrome Market by Therapeutics
7.2.4.4.2 Russia Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.4.3 Russia Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.5 Spain Guillain-Barre Syndrome Market
7.2.4.5.1 Spain Guillain-Barre Syndrome Market by Therapeutics
7.2.4.5.2 Spain Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.5.3 Spain Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.6 Italy Guillain-Barre Syndrome Market
7.2.4.6.1 Italy Guillain-Barre Syndrome Market by Therapeutics
7.2.4.6.2 Italy Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.6.3 Italy Guillain-Barre Syndrome Market by Distribution Channel
7.2.4.7 Rest of Europe Guillain-Barre Syndrome Market
7.2.4.7.1 Rest of Europe Guillain-Barre Syndrome Market by Therapeutics
7.2.4.7.2 Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration
7.2.4.7.3 Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel
7.3 Asia Pacific Guillain-Barre Syndrome Market
7.3.1 Asia Pacific Guillain-Barre Syndrome Market by Therapeutics
7.3.1.1 Asia Pacific Intravenous Immunoglobulin Market by Country
7.3.1.2 Asia Pacific Plasma Exchange Market by Country
7.3.1.3 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration
7.3.2.1 Asia Pacific Parenteral Market by Country
7.3.2.2 Asia Pacific Oral Market by Country
7.3.3 Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel
7.3.3.1 Asia Pacific Hospital Pharmacies Market by Country
7.3.3.2 Asia Pacific Retail Pharmacies Market by Country
7.3.3.3 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Guillain-Barre Syndrome Market by Country
7.3.4.1 China Guillain-Barre Syndrome Market
7.3.4.1.1 China Guillain-Barre Syndrome Market by Therapeutics
7.3.4.1.2 China Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.1.3 China Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.2 Japan Guillain-Barre Syndrome Market
7.3.4.2.1 Japan Guillain-Barre Syndrome Market by Therapeutics
7.3.4.2.2 Japan Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.2.3 Japan Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.3 India Guillain-Barre Syndrome Market
7.3.4.3.1 India Guillain-Barre Syndrome Market by Therapeutics
7.3.4.3.2 India Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.3.3 India Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.4 South Korea Guillain-Barre Syndrome Market
7.3.4.4.1 South Korea Guillain-Barre Syndrome Market by Therapeutics
7.3.4.4.2 South Korea Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.4.3 South Korea Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.5 Singapore Guillain-Barre Syndrome Market
7.3.4.5.1 Singapore Guillain-Barre Syndrome Market by Therapeutics
7.3.4.5.2 Singapore Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.5.3 Singapore Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.6 Malaysia Guillain-Barre Syndrome Market
7.3.4.6.1 Malaysia Guillain-Barre Syndrome Market by Therapeutics
7.3.4.6.2 Malaysia Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.6.3 Malaysia Guillain-Barre Syndrome Market by Distribution Channel
7.3.4.7 Rest of Asia Pacific Guillain-Barre Syndrome Market
7.3.4.7.1 Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics
7.3.4.7.2 Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration
7.3.4.7.3 Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel
7.4 LAMEA Guillain-Barre Syndrome Market
7.4.1 LAMEA Guillain-Barre Syndrome Market by Therapeutics
7.4.1.1 LAMEA Intravenous Immunoglobulin Market by Country
7.4.1.2 LAMEA Plasma Exchange Market by Country
7.4.1.3 LAMEA Others Market by Country
7.4.2 LAMEA Guillain-Barre Syndrome Market by Route Of Administration
7.4.2.1 LAMEA Parenteral Market by Country
7.4.2.2 LAMEA Oral Market by Country
7.4.3 LAMEA Guillain-Barre Syndrome Market by Distribution Channel
7.4.3.1 LAMEA Hospital Pharmacies Market by Country
7.4.3.2 LAMEA Retail Pharmacies Market by Country
7.4.3.3 LAMEA Others Market by Country
7.4.4 LAMEA Guillain-Barre Syndrome Market by Country
7.4.4.1 Brazil Guillain-Barre Syndrome Market
7.4.4.1.1 Brazil Guillain-Barre Syndrome Market by Therapeutics
7.4.4.1.2 Brazil Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.1.3 Brazil Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.2 Argentina Guillain-Barre Syndrome Market
7.4.4.2.1 Argentina Guillain-Barre Syndrome Market by Therapeutics
7.4.4.2.2 Argentina Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.2.3 Argentina Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.3 UAE Guillain-Barre Syndrome Market
7.4.4.3.1 UAE Guillain-Barre Syndrome Market by Therapeutics
7.4.4.3.2 UAE Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.3.3 UAE Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.4 Saudi Arabia Guillain-Barre Syndrome Market
7.4.4.4.1 Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics
7.4.4.4.2 Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.4.3 Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.5 South Africa Guillain-Barre Syndrome Market
7.4.4.5.1 South Africa Guillain-Barre Syndrome Market by Therapeutics
7.4.4.5.2 South Africa Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.5.3 South Africa Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.6 Nigeria Guillain-Barre Syndrome Market
7.4.4.6.1 Nigeria Guillain-Barre Syndrome Market by Therapeutics
7.4.4.6.2 Nigeria Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.6.3 Nigeria Guillain-Barre Syndrome Market by Distribution Channel
7.4.4.7 Rest of LAMEA Guillain-Barre Syndrome Market
7.4.4.7.1 Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics
7.4.4.7.2 Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration
7.4.4.7.3 Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel
Chapter 8. Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 PTC, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Novartis AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Novo Nordisk A/S
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Takeda Pharmaceutical Company Limited
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bayer AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Bristol Myers Squibb Company
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Chapter 9. Winning Imperatives of Guillain-Barre Syndrome Market
List of Tables
TABLE 1 Global Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 2 Global Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 3 Global Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 4 Global Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 5 Global Intravenous Immunoglobulin Market by Region, 2019 - 2022, USD Thousands
TABLE 6 Global Intravenous Immunoglobulin Market by Region, 2023 - 2030, USD Thousands
TABLE 7 Global Plasma Exchange Market by Region, 2019 - 2022, USD Thousands
TABLE 8 Global Plasma Exchange Market by Region, 2023 - 2030, USD Thousands
TABLE 9 Global Others Market by Region, 2019 - 2022, USD Thousands
TABLE 10 Global Others Market by Region, 2023 - 2030, USD Thousands
TABLE 11 Global Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 12 Global Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 13 Global Parenteral Market by Region, 2019 - 2022, USD Thousands
TABLE 14 Global Parenteral Market by Region, 2023 - 2030, USD Thousands
TABLE 15 Global Oral Market by Region, 2019 - 2022, USD Thousands
TABLE 16 Global Oral Market by Region, 2023 - 2030, USD Thousands
TABLE 17 Global Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 18 Global Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 19 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Thousands
TABLE 20 Global Hospital Pharmacies Market by Region, 2023 - 2030, USD Thousands
TABLE 21 Global Retail Pharmacies Market by Region, 2019 - 2022, USD Thousands
TABLE 22 Global Retail Pharmacies Market by Region, 2023 - 2030, USD Thousands
TABLE 23 Global Others Market by Region, 2019 - 2022, USD Thousands
TABLE 24 Global Others Market by Region, 2023 - 2030, USD Thousands
TABLE 25 Global Guillain-Barre Syndrome Market by Region, 2019 - 2022, USD Thousands
TABLE 26 Global Guillain-Barre Syndrome Market by Region, 2023 - 2030, USD Thousands
TABLE 27 North America Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 28 North America Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 29 North America Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 30 North America Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 31 North America Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 32 North America Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 33 North America Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 34 North America Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 35 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 36 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 37 North America Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 38 North America Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 39 North America Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 40 North America Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 41 North America Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 42 North America Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 43 North America Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 44 North America Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 45 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 46 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 47 North America Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 48 North America Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 49 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 50 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 51 North America Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 52 North America Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 53 US Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 54 US Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 55 US Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 56 US Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 57 US Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 58 US Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 59 US Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 60 US Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 61 Canada Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 62 Canada Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 63 Canada Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 64 Canada Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 65 Canada Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 66 Canada Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 67 Canada Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 68 Canada Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 69 Mexico Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 70 Mexico Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 71 Mexico Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 72 Mexico Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 73 Mexico Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 74 Mexico Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 75 Mexico Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 76 Mexico Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 77 Rest of North America Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 78 Rest of North America Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 79 Rest of North America Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 80 Rest of North America Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 81 Rest of North America Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 82 Rest of North America Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 83 Rest of North America Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 84 Rest of North America Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 85 Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 86 Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 87 Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 88 Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 89 Europe Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 90 Europe Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 91 Europe Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 92 Europe Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 93 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 94 Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 95 Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 96 Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 97 Europe Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 98 Europe Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 99 Europe Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 100 Europe Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 101 Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 102 Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 103 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 104 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 105 Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 106 Europe Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 107 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 108 Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 109 Europe Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 110 Europe Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 111 Germany Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 112 Germany Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 113 Germany Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 114 Germany Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 115 Germany Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 116 Germany Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 117 Germany Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 118 Germany Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 119 UK Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 120 UK Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 121 UK Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 122 UK Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 123 UK Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 124 UK Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 125 UK Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 126 UK Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 127 France Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 128 France Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 129 France Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 130 France Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 131 France Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 132 France Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 133 France Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 134 France Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 135 Russia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 136 Russia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 137 Russia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 138 Russia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 139 Russia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 140 Russia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 141 Russia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 142 Russia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 143 Spain Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 144 Spain Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 145 Spain Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 146 Spain Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 147 Spain Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 148 Spain Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 149 Spain Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 150 Spain Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 151 Italy Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 152 Italy Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 153 Italy Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 154 Italy Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 155 Italy Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 156 Italy Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 157 Italy Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 158 Italy Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 159 Rest of Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 160 Rest of Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 161 Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 162 Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 163 Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 164 Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 165 Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 166 Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 167 Asia Pacific Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 168 Asia Pacific Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 169 Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 170 Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 171 Asia Pacific Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 172 Asia Pacific Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 173 Asia Pacific Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 174 Asia Pacific Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 175 Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
TABLE 176 Asia Pacific Others Market by Country, 2023 - 2030, USD Thousands
TABLE 177 Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 178 Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 179 Asia Pacific Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 180 Asia Pacific Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 181 Asia Pacific Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 182 Asia Pacific Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 183 Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 184 Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 185 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 186 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 187 Asia Pacific Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 188 Asia Pacific Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 189 Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
TABLE 190 Asia Pacific Others Market by Country, 2023 - 2030, USD Thousands
TABLE 191 Asia Pacific Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 192 Asia Pacific Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 193 China Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 194 China Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 195 China Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 196 China Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 197 China Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 198 China Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 199 China Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 200 China Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 201 Japan Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 202 Japan Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 203 Japan Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 204 Japan Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 205 Japan Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 206 Japan Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 207 Japan Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 208 Japan Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 209 India Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 210 India Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 211 India Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 212 India Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 213 India Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 214 India Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 215 India Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 216 India Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 217 South Korea Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 218 South Korea Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 219 South Korea Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 220 South Korea Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 221 South Korea Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 222 South Korea Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 223 South Korea Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 224 South Korea Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 225 Singapore Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 226 Singapore Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 227 Singapore Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 228 Singapore Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 229 Singapore Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 230 Singapore Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 231 Singapore Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 232 Singapore Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 233 Malaysia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 234 Malaysia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 235 Malaysia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 236 Malaysia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 237 Malaysia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 238 Malaysia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 239 Malaysia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 240 Malaysia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 241 Rest of Asia Pacific Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 242 Rest of Asia Pacific Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 243 Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 244 Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 245 Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 246 Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 247 Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 248 Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 249 LAMEA Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 250 LAMEA Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 251 LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 252 LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 253 LAMEA Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 254 LAMEA Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 255 LAMEA Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 256 LAMEA Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 257 LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 258 LAMEA Others Market by Country, 2023 - 2030, USD Thousands
TABLE 259 LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 260 LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 261 LAMEA Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 262 LAMEA Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 263 LAMEA Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 264 LAMEA Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 265 LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 266 LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 267 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 268 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 269 LAMEA Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 270 LAMEA Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 271 LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 272 LAMEA Others Market by Country, 2023 - 2030, USD Thousands
TABLE 273 LAMEA Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 274 LAMEA Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 275 Brazil Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 276 Brazil Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 277 Brazil Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 278 Brazil Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 279 Brazil Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 280 Brazil Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 281 Brazil Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 282 Brazil Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 283 Argentina Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 284 Argentina Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 285 Argentina Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 286 Argentina Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 287 Argentina Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 288 Argentina Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 289 Argentina Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 290 Argentina Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 291 UAE Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 292 UAE Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 293 UAE Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 294 UAE Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 295 UAE Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 296 UAE Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 297 UAE Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 298 UAE Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 299 Saudi Arabia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 300 Saudi Arabia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 301 Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 302 Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 303 Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 304 Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 305 Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 306 Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 307 South Africa Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 308 South Africa Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 309 South Africa Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 310 South Africa Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 311 South Africa Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 312 South Africa Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 313 South Africa Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 314 South Africa Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 315 Nigeria Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 316 Nigeria Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 317 Nigeria Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 318 Nigeria Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 319 Nigeria Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 320 Nigeria Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 321 Nigeria Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 322 Nigeria Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 323 Rest of LAMEA Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 324 Rest of LAMEA Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 325 Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 326 Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 327 Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 328 Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 329 Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 330 Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 331 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 332 Key Information – Pfizer, Inc.
TABLE 333 key Information – PTC, Inc.
TABLE 334 KEY INFORMATION – AstraZeneca PLC
TABLE 335 Key Information – Novartis AG
TABLE 336 Key Information – Novo Nordisk A/S
TABLE 337 Key Information – Takeda Pharmaceutical Company Limited
TABLE 338 Key Information – Bayer AG
TABLE 339 Key Information - Merck & Co., Inc.
TABLE 340 Key Information – Bristol Myers Squibb Company
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Guillain-Barre Syndrome Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting Guillain-Barre Syndrome Market
FIG 4 Porter’s Five Forces Analysis – Guillain-Barre Syndrome Market
FIG 5 Global Guillain-Barre Syndrome Market share by Therapeutics, 2022
FIG 6 Global Guillain-Barre Syndrome Market share by Therapeutics, 2030
FIG 7 Global Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2030, USD Thousands
FIG 8 Global Guillain-Barre Syndrome Market share by Route Of Administration, 2022
FIG 9 Global Guillain-Barre Syndrome Market share by Route Of Administration, 2030
FIG 10 Global Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2030, USD Thousands
FIG 11 Global Guillain-Barre Syndrome Market share by Distribution Channel, 2022
FIG 12 Global Guillain-Barre Syndrome Market share by Distribution Channel, 2030
FIG 13 Global Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2030, USD Thousands
FIG 14 Global Guillain-Barre Syndrome Market share by Region, 2022
FIG 15 Global Guillain-Barre Syndrome Market share by Region, 2030
FIG 16 Global Guillain-Barre Syndrome Market by Region, 2019 - 2030, USD Thousands
FIG 17 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 18 SWOT Analysis: Pfizer, Inc.
FIG 19 SWOT Analysis: PTC, Inc.
FIG 20 SWOT Analysis: AstraZeneca PLC
FIG 21 SWOT Analysis: Novartis AG
FIG 22 SWOT Analysis: Novo Nordisk A/S
FIG 23 SWOT Analysis:Takeda Pharmaceutical Company Limited
FIG 24 Swot Analysis: Bayer AG
FIG 25 SWOT Analysis: Merck & Co., Inc.
FIG 26 SWOT Analysis: Bristol Myers Squibb Company
TABLE 2 Global Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 3 Global Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 4 Global Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 5 Global Intravenous Immunoglobulin Market by Region, 2019 - 2022, USD Thousands
TABLE 6 Global Intravenous Immunoglobulin Market by Region, 2023 - 2030, USD Thousands
TABLE 7 Global Plasma Exchange Market by Region, 2019 - 2022, USD Thousands
TABLE 8 Global Plasma Exchange Market by Region, 2023 - 2030, USD Thousands
TABLE 9 Global Others Market by Region, 2019 - 2022, USD Thousands
TABLE 10 Global Others Market by Region, 2023 - 2030, USD Thousands
TABLE 11 Global Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 12 Global Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 13 Global Parenteral Market by Region, 2019 - 2022, USD Thousands
TABLE 14 Global Parenteral Market by Region, 2023 - 2030, USD Thousands
TABLE 15 Global Oral Market by Region, 2019 - 2022, USD Thousands
TABLE 16 Global Oral Market by Region, 2023 - 2030, USD Thousands
TABLE 17 Global Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 18 Global Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 19 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Thousands
TABLE 20 Global Hospital Pharmacies Market by Region, 2023 - 2030, USD Thousands
TABLE 21 Global Retail Pharmacies Market by Region, 2019 - 2022, USD Thousands
TABLE 22 Global Retail Pharmacies Market by Region, 2023 - 2030, USD Thousands
TABLE 23 Global Others Market by Region, 2019 - 2022, USD Thousands
TABLE 24 Global Others Market by Region, 2023 - 2030, USD Thousands
TABLE 25 Global Guillain-Barre Syndrome Market by Region, 2019 - 2022, USD Thousands
TABLE 26 Global Guillain-Barre Syndrome Market by Region, 2023 - 2030, USD Thousands
TABLE 27 North America Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 28 North America Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 29 North America Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 30 North America Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 31 North America Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 32 North America Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 33 North America Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 34 North America Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 35 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 36 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 37 North America Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 38 North America Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 39 North America Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 40 North America Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 41 North America Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 42 North America Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 43 North America Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 44 North America Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 45 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 46 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 47 North America Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 48 North America Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 49 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 50 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 51 North America Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 52 North America Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 53 US Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 54 US Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 55 US Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 56 US Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 57 US Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 58 US Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 59 US Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 60 US Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 61 Canada Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 62 Canada Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 63 Canada Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 64 Canada Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 65 Canada Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 66 Canada Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 67 Canada Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 68 Canada Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 69 Mexico Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 70 Mexico Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 71 Mexico Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 72 Mexico Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 73 Mexico Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 74 Mexico Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 75 Mexico Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 76 Mexico Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 77 Rest of North America Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 78 Rest of North America Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 79 Rest of North America Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 80 Rest of North America Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 81 Rest of North America Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 82 Rest of North America Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 83 Rest of North America Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 84 Rest of North America Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 85 Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 86 Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 87 Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 88 Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 89 Europe Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 90 Europe Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 91 Europe Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 92 Europe Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 93 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 94 Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 95 Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 96 Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 97 Europe Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 98 Europe Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 99 Europe Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 100 Europe Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 101 Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 102 Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 103 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 104 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 105 Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 106 Europe Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 107 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 108 Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 109 Europe Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 110 Europe Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 111 Germany Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 112 Germany Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 113 Germany Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 114 Germany Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 115 Germany Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 116 Germany Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 117 Germany Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 118 Germany Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 119 UK Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 120 UK Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 121 UK Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 122 UK Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 123 UK Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 124 UK Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 125 UK Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 126 UK Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 127 France Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 128 France Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 129 France Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 130 France Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 131 France Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 132 France Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 133 France Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 134 France Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 135 Russia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 136 Russia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 137 Russia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 138 Russia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 139 Russia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 140 Russia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 141 Russia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 142 Russia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 143 Spain Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 144 Spain Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 145 Spain Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 146 Spain Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 147 Spain Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 148 Spain Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 149 Spain Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 150 Spain Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 151 Italy Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 152 Italy Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 153 Italy Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 154 Italy Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 155 Italy Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 156 Italy Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 157 Italy Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 158 Italy Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 159 Rest of Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 160 Rest of Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 161 Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 162 Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 163 Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 164 Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 165 Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 166 Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 167 Asia Pacific Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 168 Asia Pacific Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 169 Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 170 Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 171 Asia Pacific Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 172 Asia Pacific Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 173 Asia Pacific Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 174 Asia Pacific Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 175 Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
TABLE 176 Asia Pacific Others Market by Country, 2023 - 2030, USD Thousands
TABLE 177 Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 178 Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 179 Asia Pacific Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 180 Asia Pacific Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 181 Asia Pacific Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 182 Asia Pacific Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 183 Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 184 Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 185 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 186 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 187 Asia Pacific Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 188 Asia Pacific Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 189 Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
TABLE 190 Asia Pacific Others Market by Country, 2023 - 2030, USD Thousands
TABLE 191 Asia Pacific Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 192 Asia Pacific Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 193 China Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 194 China Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 195 China Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 196 China Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 197 China Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 198 China Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 199 China Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 200 China Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 201 Japan Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 202 Japan Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 203 Japan Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 204 Japan Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 205 Japan Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 206 Japan Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 207 Japan Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 208 Japan Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 209 India Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 210 India Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 211 India Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 212 India Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 213 India Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 214 India Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 215 India Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 216 India Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 217 South Korea Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 218 South Korea Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 219 South Korea Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 220 South Korea Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 221 South Korea Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 222 South Korea Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 223 South Korea Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 224 South Korea Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 225 Singapore Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 226 Singapore Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 227 Singapore Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 228 Singapore Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 229 Singapore Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 230 Singapore Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 231 Singapore Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 232 Singapore Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 233 Malaysia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 234 Malaysia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 235 Malaysia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 236 Malaysia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 237 Malaysia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 238 Malaysia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 239 Malaysia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 240 Malaysia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 241 Rest of Asia Pacific Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 242 Rest of Asia Pacific Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 243 Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 244 Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 245 Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 246 Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 247 Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 248 Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 249 LAMEA Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 250 LAMEA Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 251 LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 252 LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 253 LAMEA Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 254 LAMEA Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 255 LAMEA Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 256 LAMEA Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 257 LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 258 LAMEA Others Market by Country, 2023 - 2030, USD Thousands
TABLE 259 LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 260 LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 261 LAMEA Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 262 LAMEA Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 263 LAMEA Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 264 LAMEA Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 265 LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 266 LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 267 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 268 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 269 LAMEA Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 270 LAMEA Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 271 LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 272 LAMEA Others Market by Country, 2023 - 2030, USD Thousands
TABLE 273 LAMEA Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 274 LAMEA Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 275 Brazil Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 276 Brazil Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 277 Brazil Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 278 Brazil Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 279 Brazil Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 280 Brazil Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 281 Brazil Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 282 Brazil Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 283 Argentina Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 284 Argentina Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 285 Argentina Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 286 Argentina Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 287 Argentina Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 288 Argentina Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 289 Argentina Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 290 Argentina Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 291 UAE Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 292 UAE Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 293 UAE Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 294 UAE Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 295 UAE Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 296 UAE Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 297 UAE Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 298 UAE Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 299 Saudi Arabia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 300 Saudi Arabia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 301 Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 302 Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 303 Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 304 Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 305 Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 306 Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 307 South Africa Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 308 South Africa Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 309 South Africa Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 310 South Africa Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 311 South Africa Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 312 South Africa Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 313 South Africa Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 314 South Africa Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 315 Nigeria Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 316 Nigeria Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 317 Nigeria Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 318 Nigeria Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 319 Nigeria Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 320 Nigeria Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 321 Nigeria Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 322 Nigeria Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 323 Rest of LAMEA Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 324 Rest of LAMEA Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 325 Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 326 Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 327 Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 328 Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 329 Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 330 Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 331 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 332 Key Information – Pfizer, Inc.
TABLE 333 key Information – PTC, Inc.
TABLE 334 KEY INFORMATION – AstraZeneca PLC
TABLE 335 Key Information – Novartis AG
TABLE 336 Key Information – Novo Nordisk A/S
TABLE 337 Key Information – Takeda Pharmaceutical Company Limited
TABLE 338 Key Information – Bayer AG
TABLE 339 Key Information - Merck & Co., Inc.
TABLE 340 Key Information – Bristol Myers Squibb Company
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Guillain-Barre Syndrome Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting Guillain-Barre Syndrome Market
FIG 4 Porter’s Five Forces Analysis – Guillain-Barre Syndrome Market
FIG 5 Global Guillain-Barre Syndrome Market share by Therapeutics, 2022
FIG 6 Global Guillain-Barre Syndrome Market share by Therapeutics, 2030
FIG 7 Global Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2030, USD Thousands
FIG 8 Global Guillain-Barre Syndrome Market share by Route Of Administration, 2022
FIG 9 Global Guillain-Barre Syndrome Market share by Route Of Administration, 2030
FIG 10 Global Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2030, USD Thousands
FIG 11 Global Guillain-Barre Syndrome Market share by Distribution Channel, 2022
FIG 12 Global Guillain-Barre Syndrome Market share by Distribution Channel, 2030
FIG 13 Global Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2030, USD Thousands
FIG 14 Global Guillain-Barre Syndrome Market share by Region, 2022
FIG 15 Global Guillain-Barre Syndrome Market share by Region, 2030
FIG 16 Global Guillain-Barre Syndrome Market by Region, 2019 - 2030, USD Thousands
FIG 17 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 18 SWOT Analysis: Pfizer, Inc.
FIG 19 SWOT Analysis: PTC, Inc.
FIG 20 SWOT Analysis: AstraZeneca PLC
FIG 21 SWOT Analysis: Novartis AG
FIG 22 SWOT Analysis: Novo Nordisk A/S
FIG 23 SWOT Analysis:Takeda Pharmaceutical Company Limited
FIG 24 Swot Analysis: Bayer AG
FIG 25 SWOT Analysis: Merck & Co., Inc.
FIG 26 SWOT Analysis: Bristol Myers Squibb Company